Intuitive Surgical Aktie News

Intuitive Surgical is the 800-pound gorilla in the robotic surgery realm. It has more than 11,000 systems installed worldwide.

Palantir's stock has been soaring in recent years to a valuation that simply looks unsustainable. Uber Technologies and Intuitive Surgical have some promising growth prospects and may possess more upside.

Intuitive Surgical's growth rate was around 19% last quarter. The company has been growing steadily over the years, and it still has plenty of potential in the long term.

Intuitive Surgical is the world's No. 1 robotic surgery company.

Intuitive Surgical's recent dip is a good buying opportunity, considering its prospects. Vertex Pharmaceuticals' shares could jump this year as it advances its clinical programs.

Intuitive Surgical makes the da Vinci surgical robot. The company is growing strongly but has a lofty price tag.

Intuitive Surgical remains a compelling long-term buy despite recent share price weakness and mixed Q4 results. Da Vinci 5 adoption is robust, with 74% YoY system placement growth and expanding FDA-approved use cases. 2026 guidance is soft, with procedure growth expected to slow to 13–15%, but headwinds are seen as temporary.

Intuitive Surgical is an industry leader in surgical robotics. The company continues to sell many da Vinci systems, which power its parts and services revenue.